Assenagon Asset Management S.A. Repligen Corp Transaction History

Assenagon Asset Management S.A.

$65.1 Billion
Q3 2025

A detailed history of Assenagon Asset Management S.A. transactions in Repligen Corp stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 40,569 shares of RGEN stock, worth $6.54 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

40,569

Holding current value

$6.54 Million

% of portfolio

0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 07, 2025	BUY	$111.43 - $134.0 $4.52 Million - $5.44 Million	40,569 New	40,569 $5.42 Million
Q2 2024 Jul 18, 2024	BUY	$120.0 - $182.95 $3.27 Million - $4.99 Million	27,280 Added 937.78%	30,189 $3.81 Million
Q1 2024 Apr 24, 2024	SELL	$170.78 - $208.42 $12,466 - $15,214	-73 Reduced 2.45%	2,909 $535,000
Q4 2023 Jan 17, 2024	BUY	$114.17 - $185.35 $5,594 - $9,082	49 Added 1.67%	2,982 $536,000
Q3 2023 Nov 06, 2023	SELL	$138.78 - $176.51 $2,636 - $3,353	-19 Reduced 0.64%	2,933 $466,000
Q2 2023 Jul 25, 2023	SELL	$138.42 - $180.31 $8,305 - $10,818	-60 Reduced 1.99%	2,952 $417,000
Q1 2023 Apr 18, 2023	SELL	$154.26 - $198.1 $28,075 - $36,054	-182 Reduced 5.7%	3,012 $507,000
Q4 2022 Jan 12, 2023	BUY	$162.42 - $220.56 $112,719 - $153,068	694 Added 27.76%	3,194 $541,000
Q3 2022 Oct 27, 2022	BUY	$160.42 - $256.21 $18,127 - $28,951	113 Added 4.73%	2,500 $468,000
Q2 2022 Jul 27, 2022	SELL	$140.68 - $188.02 $6.54 Million - $8.73 Million	-46,455 Reduced 95.11%	2,387 $388,000
Q1 2022 Apr 25, 2022	BUY	$161.19 - $257.96 $6.66 Million - $10.7 Million	41,343 Added 551.31%	48,842 $9.19 Million
Q4 2021 Feb 01, 2022	BUY	$247.59 - $304.47 $1.56 Million - $1.92 Million	6,301 Added 525.96%	7,499 $1.99 Million
Q3 2021 Oct 19, 2021	SELL	$194.77 - $324.21 $7.96 Million - $13.3 Million	-40,879 Reduced 97.15%	1,198 $346,000
Q2 2021 Jul 15, 2021	SELL	$165.87 - $220.95 $1.38 Million - $1.84 Million	-8,312 Reduced 16.5%	42,077 $8.4 Million
Q1 2021 Apr 26, 2021	BUY	$180.37 - $226.26 $3.33 Million - $4.18 Million	18,486 Added 57.94%	50,389 $9.8 Million
Q4 2020 Feb 01, 2021	BUY	$148.08 - $206.57 $2.78 Million - $3.88 Million	18,760 Added 142.74%	31,903 $6.11 Million
Q3 2020 Oct 07, 2020	BUY	$122.51 - $158.27 $1.61 Million - $2.08 Million	13,143 New	13,143 $1.94 Million
Q1 2020 Apr 17, 2020	SELL	$84.96 - $109.14 $1.08 Million - $1.39 Million	-12,741 Closed	0 $0
Q4 2019 Jan 17, 2020	BUY	$73.84 - $93.08 $940,795 - $1.19 Million	12,741 New	12,741 $1.18 Million
Q1 2018 Apr 30, 2018	SELL	$30.92 - $37.27 $624,584 - $752,854	-20,200 Closed	0 $0
Q4 2017 Jan 25, 2018	SELL	$32.53 - $38.92 $1.86 Million - $2.22 Million	-57,160 Reduced 73.89%	20,200 $733,000
Q3 2017 Oct 18, 2017	BUY	$36.98 - $46.06 $2.86 Million - $3.56 Million	77,360	77,360 $2.96 Million

Others Institutions Holding RGEN

# of Institutions

513

Shares Held

59M

Call Options Held

89.3K

Put Options Held

679K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.94B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.

Account

Assenagon Asset Management S.A. Repligen Corp Transaction History